NOVEN PHARMACEUTICALS INC.
History
| Year | Detail |
|---|---|
| 1987 | Founded in 1987 by Steven Sablotsky, Noven Pharmaceuticals Inc. specializes in developing and manufacturing advanced transdermal drug delivery products, technologies, and prescription transdermal products. |
| 1999 | The company launched Vivelle-Dot (estradiol transdermal system), which was the world's smallest estrogen patch at the time. |
| 2007 | The company acquired JDS Pharmaceuticals LLC, a privately held specialty pharmaceutical company that marketed two branded prescription psychiatry products, for approximately $125 million in cash. |
| 2009 | To expand into the U.S., Noven was acquired by Hisamitsu Pharmaceutical Co. Ltd., a Japanese company that began manufacturing and marketing prescription drugs during the 1970s. |
| 2012 | The company acquired commercial rights to Minivelle (estradiol transdermal system) in the U.S. and Canada from Novogyne Pharmaceuticals, a women’s health joint venture between Noven and Novartis. |
| 2023 | The company launched XELSTRYM, a transdermal patch for the treatment of ADHD. It marked the first and only once-daily amphetamine transdermal patch available for both adults and pediatric patients 6 years and older. |